Evidence map›Paper›PMID 36873547›Full record

ArticleHeliyon2023

Anti-

Abdellatif Bouazzaoui, Neda M Bogari, Faisal A Al-Allaf, Samar N Ekram, Mohammad Athar, Anas Dannoun, Thomas Schubert, Shahzad N Syed, Abdel-Rahman Youssef, Mashael Alqahtani and 1 more

Erratum issuedOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Latest Findings in Immunoglobulin Y Technologies and Applications.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Abdellatif BouazzaouiDepartment of Medical Genetics, Faculty of Medicine, Umm Al-Qura University, 21955, Makkah, Saudi Arabia.
Neda M BogariDepartment of Medical Genetics, Faculty of Medicine, Umm Al-Qura University, 21955, Makkah, Saudi Arabia.
Faisal A Al-AllafDepartment of Medical Genetics, Faculty of Medicine, Umm Al-Qura University, 21955, Makkah, Saudi Arabia.
Samar N EkramDepartment of Medical Genetics, Faculty of Medicine, Umm Al-Qura University, 21955, Makkah, Saudi Arabia.
Mohammad AtharDepartment of Medical Genetics, Faculty of Medicine, Umm Al-Qura University, 21955, Makkah, Saudi Arabia.
Anas DannounDepartment of Medical Genetics, Faculty of Medicine, Umm Al-Qura University, 21955, Makkah, Saudi Arabia.
Thomas SchubertInstitut für angewandte Pathologie Speyer, Alter Postweg 1, 67346, Speyer, Germany.
Shahzad N SyedInstitute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, 60590 Frankfurt, Germany.
Abdel-Rahman YoussefDepartment of Basic and Clinical Oral Sciences, Faculty of Dentistry, Umm Al-Qura University, 21955, Makkah, Saudi Arabia.
Mashael AlqahtaniDepartment of Basic and Clinical Oral Sciences, Faculty of Dentistry, Umm Al-Qura University, 21955, Makkah, Saudi Arabia.
Ahmed A H AbdellatifDepartment of Pharmaceutics, College of Pharmacy, Qassim University, 51452, Qassim, Saudi Arabia.
Umm al-Qura University · SAGoethe University Frankfurt · DEQassim University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Graft versus host disease (GVHD) remains the major cause of morbidity and mortality after allogeneic stem cell transplantation, especially for intestinal GVHD, as steroid resistant GVHD results in high mortality. For this reason, new treatments of GVHD are needed. One approach is the reduction of pathogenic bacteria using anti-

Indexed as

Bone marrow transplantationE. coliGraft-versus-host diseaseHen antibody Immunoglobulin Yolk (IgY)PRR cytokines And chemokinesStem cell transplantation

Identifiers

PMID36873547
PMCPMC9982617
OpenAlexW4321502941

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.